News

Highlights: Malaysia’s halal pharmaceutical industry, under the jurisdiction of the Department of Islamic Development Malaysia (Jakim) and the National Pharmaceutical Regulatory Authority (NPRA), has seen significant growth due to rising global demand for halal-certified products. The Halal Pharmaceuticals Standard MS2424 ensures adherence to both regulatory and halal aspects. Key players like Duopharma Biotech, Pharmaniaga, and Ain Medicare, along with the Halal Development Corp, play crucial roles in the industry. The government’s Halal Industry Master Plan 2030 (HIMP 2030) positions halal-certified pharmaceuticals as a major post-pandemic economic initiative. Despite challenges in global expansion due to diverse halal certification standards, Malaysia, a pioneer in the halal pharmaceutical industry, remains confident in maintaining its global position and continues to leverage opportunities to demonstrate its expertise in producing high-quality halal pharmaceuticals.

Link to Original Article

https://themalaysianreserve.com/2023/12/26/malaysia-leads-global-halal-pharmaceutical-industry/